CANF Can-Fite BioPharma Ltd.
NEUTRAL
Impact: 2/10
6-K
Notable filing: 6-K
Latest settled — T+5d
CANF ▼ -7.76% at T+5d
NEUTRAL call ✗ call lost -7.76% · α vs SPY -5.26% · entry $3.35 → $3.09
Currently $2.84 · -15.22% from $3.35 entry
T+1d
-3.28%
call -3.28% · α -3.54%
$3.24
settled 15d ago
T+5d
-7.76%
call -7.76% · α -5.26%
$3.09
settled 9d ago
T+20d
—
call — · α —
—
in 13d
T+60d
—
call — · α —
—
in 2mo
Price Chart
Loading chart...
Executive Summary
Can-Fite BioPharma's 2026 Annual General Meeting of Shareholders was adjourned due to lack of quorum and rescheduled for June 4, 2026. This is a routine procedural event with no material financial or operational impact.
Actionable Insight
Monitor the reconvened meeting on June 4 for any shareholder proposals or voting outcomes that could affect governance or capital structure. No immediate trading action warranted.
Key Facts
- Annual General Meeting convened on May 28, 2026 was adjourned for one week due to lack of quorum.
- Meeting reconvened on June 4, 2026 at 3:00 p.m. Israel time at company offices.
- No proposals, voting results, or business conducted were disclosed in the filing.
Financial Impact
No financial impact — adjournment is a procedural delay only.
Risk Factors
- Lack of quorum may indicate low shareholder engagement, but no direct financial risk.
- No material business was disclosed; adjournment alone is not a catalyst.
Market Snapshot
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
75% bullish (8 analysts)
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-062151 |
| Document: 0001213900-26-062151-index-headers.html | 0001213900-26-062151 |
| Document: 0001213900-26-062151-index.html | 0001213900-26-062151 |
| Document: 0001213900-26-062151.txt | 0001213900-26-062151 |
14 reports for CANF
100%
Hit rate
best @ T+20▲ +5.33%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 4, 2026
8d ago
|
6-K
| $3.20 awaiting T+1 | awaiting T+1 | — | $2.84 (−11.25%) |
|
Jun 2, 2026
10d ago
|
6-K
| $3.11 $3.11 | · 0.00% | ▲ +0.69% | $2.84 (−8.68%) |
|
May 28, 2026
15d ago
|
6-K
| $3.35 $3.24 | ▼ −3.28% | ▼ −3.54% | $2.84 (−15.22%) |
|
May 13, 2026
4w ago
|
6-K
| $3.64 $3.49 | ▼ −4.12% | ▼ −4.90% | $2.84 (−21.98%) |
|
Apr 30, 2026
6w ago
|
6-K
| $3.19 $2.93 | ▼ −8.15% | ▼ −8.37% | $2.84 (−10.97%) |
|
Apr 23, 2026
7w ago
|
6-K
| $2.91 $2.92 | ▲ +0.34% | ▲ +0.18% | $2.84 (−2.41%) |
|
Apr 6, 2026
9w ago
|
EFFECT
| $3.06 $3.03 | ▼ −0.98% | ▼ −1.04% | $2.84 (−7.19%) |
|
Apr 1, 2026
10w ago
|
EFFECT
| $3.09 $3.07 | ▼ −0.65% | ▼ −0.73% | $2.84 (−8.09%) |
|
Mar 30, 2026
10w ago
|
6-K
| $3.01 $3.10 | ▲ +2.99% | ▲ +0.10% | $2.84 (−5.65%) |
|
Mar 30, 2026
10w ago
|
Press Release
| $3.01 $3.10 | ▲ +2.99% | ▲ +0.10% | $2.84 (−5.65%) |
Showing 10 of 14
US Market Status
Market Closed — Opens Mon (53h 8m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access